Eton Pharmaceuticals (ETON) Operating Leases (2019 - 2025)
Historic Operating Leases for Eton Pharmaceuticals (ETON) over the last 7 years, with Q3 2025 value amounting to $480000.0.
- Eton Pharmaceuticals' Operating Leases rose 28095.24% to $480000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $480000.0, marking a year-over-year increase of 28095.24%. This contributed to the annual value of $107000.0 for FY2024, which is 38636.36% up from last year.
- Per Eton Pharmaceuticals' latest filing, its Operating Leases stood at $480000.0 for Q3 2025, which was up 28095.24% from $492000.0 recorded in Q2 2025.
- In the past 5 years, Eton Pharmaceuticals' Operating Leases registered a high of $492000.0 during Q2 2025, and its lowest value of $15000.0 during Q4 2021.
- Moreover, its 5-year median value for Operating Leases was $79000.0 (2021), whereas its average is $116315.8.
- In the last 5 years, Eton Pharmaceuticals' Operating Leases tumbled by 8484.85% in 2021 and then soared by 61333.33% in 2022.
- Eton Pharmaceuticals' Operating Leases (Quarter) stood at $15000.0 in 2021, then soared by 613.33% to $107000.0 in 2022, then crashed by 79.44% to $22000.0 in 2023, then skyrocketed by 386.36% to $107000.0 in 2024, then skyrocketed by 348.6% to $480000.0 in 2025.
- Its last three reported values are $480000.0 in Q3 2025, $492000.0 for Q2 2025, and $87000.0 during Q1 2025.